Press release
Imatinib Drug Market Size, Share, Growth, Industry Analysis, Opportunities and Forecast 2020-2026
FDA approval of imatinib drug for the treatment of different types of cancers by the major players propelling the growth of the imatinib drug market. For instance, in July 2019, Lupin Ltd. announced the launch of Imatinib Mesylate tablets, 100mg (base) and 400 mg (base). Lupin alliance partner Natco had received approval from the US FDA earlier. Lupin’s Imatinib Mesylate Tablet, 100 mg (base) and 400 mg (base) is the generic version of Novartis Pharmaceuticals Corp's Gleevec tablets 100mg and 400 mg.A full report of Imatinib Drug Market is available at: https://www.omrglobal.com/industry-reports/imatinib-drug-market
In October 2018, Dr. Reddy’s Laboratories, Ltd. announced the launch of its Imatinib Mesylate Tablets, USP, a therapeutic equivalent generic version Gleevec tablets in the United States market for the treatment of different types of cancer. Imatinib Mesylate is a US FDA approved drug for commercial sale in the US which is expected to boost the imatinib market in the country. Imatinib Mesylate tablets are available in two different strengths i.e. 100 mg and 400 mg.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/imatinib-drug-market
In September 2017, Mylan N.V. announced the US launch of Imatinib Mesylate Tablets in 100 mg and 400 mg generic version. Mylan received final approval from the U.S Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product. Imatinib Mesylate tablets can be used for multiple indications including Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), hypereosinophilic syndrome (HES) and aggressive systemic mastocytosis (ASM).
Imatinib Drug Market Segmentation
By Drug Form
• Tablet
• Capsule
By Application
• Blood Cancer (Leukemia and Other Blood Cancers)
• Gastrointestinal Stromal Tumors (GIST)
• Skin Tumors (Dermatofibrosarcoma Protuberans)
• Other Tumors (Systemic Mastocytosis)
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/imatinib-drug-market
Imatinib Drug Market – Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Apotex Inc.
• Cipla, Inc.
• Dr. Reddy’s Laboratory, Ltd.
• Glenmark Pharmaceutical, Ltd.
• Lupin, Ltd.
• Mylan N.V.
• Novartis AG
• Sun Pharmaceutical Industries, Ltd.
• Teva Pharmaceutical Industry, Ltd.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Imatinib Drug Market Size, Share, Growth, Industry Analysis, Opportunities and Forecast 2020-2026 here
News-ID: 2216659 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Imatinib
Imatinib Drug Market 2025 | Investment Opportunities, Market Size & Future Oppor …
Market Size and Growth
The Global Imatinib Drug Market is estimated to reach at a Significant CAGR during the forecast period (2024-2031).
Key Development:
✅ In August 2025, a study by Kidoguchi et al. in Internal Medicine reported that although generic imatinib has been available in Japan since 2014 at about 50-55% of the original price, brand-name Gleevec® still held ~72% market share in Fiscal Year 2022. One factor highlighted is Japan's…
Imatinib Mesylate Drugs Market By Industry Research, Supply, Size, Share and Pro …
The "Imatinib Mesylate Pharmaceuticals Market" 2023 research report offers insight into a global business study with key competitors functioning in the sector and a look at how the market will likely compete in the future. The Imatinib Mesylate Drugs market report created by our experts is a fantastic piece of work that takes into account obstacles and chances while also considering the growth of Imatinib Mesylate Drugs, shares, and revenue…
Imatinib Drug Market Report- Business Review, Technology, Top Companies and Tren …
The Imatinib Drug Market research report studies the competitive development of the Imatinib Drug Market, such as agreements, new product launches, expansions, and acquisitions in the market. In addition, Imatinib Drug Market provides a region-wise study of the market, including North America, Asia Pacific, Latin America, Middle East, Africa, and Europe. It helps stakeholders understand market players and analyze the top 25 organizations based on their product footprint, market strength,…
Global Imatinib Drug Market Size | COVID-19 Impact Analysis | Forecast to 2027
The global imatinib drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to accelerate the growth of the market includes an increase in the prevalence of cancer and an increase in demand for target drug therapy. For instance, according to National Cancer Institute in 2017, the number of new leukemia cases was 62,130 and the number of mortalities…
Imatinib Drug Market Growth, Size, Share, Industry Report and Forecast 2020-2026
FDA approval of imatinib drug for the treatment of different types of cancers by the major players propelling the growth of the imatinib drug market. For instance, in July 2019, Lupin Ltd. announced the launch of Imatinib Mesylate tablets, 100mg (base) and 400 mg (base). Lupin alliance partner Natco had received approval from the US FDA earlier. Lupin’s Imatinib Mesylate Tablet, 100 mg (base) and 400 mg (base) is the…
Imatinib Drug Market Size, Competitive Analysis, Share, Forecast- 2020-2026
The global imatinib drug market is estimated to grow at a CAGR of around 4% during the forecast period. The major factors contributing to the growth of the market include the rising prevalence of cancer and an increase in awareness programs towards cancer by government and private organizations. Imatinib is a chemotherapy drug that used to slow down or stopping the growth of the cancer cells. This medication is used…
